| RS1560929669 |
TBCK
|
Health Risk |
Likely pathogenic |
Hypotonia, infantile |
| RS1560929898 |
LARP7
|
Health Risk |
Likely pathogenic |
Microcephalic primordial dwarfism, Alazami type |
| RS1560938296 |
LRBA
|
Health Risk |
Pathogenic |
Combined immunodeficiency due to LRBA deficiency, Combined immunodeficiency due to LRBA deficiency |
| RS1560949756 |
NR3C2
|
Health Risk |
Pathogenic |
Autosomal dominant pseudohypoaldosteronism type 1, Autosomal dominant pseudohypoaldosteronism type 1 |
| RS1560950739 |
AGA
|
Health Risk |
Pathogenic |
Aspartylglucosaminuria, Aspartylglucosaminuria |
| RS1560950756 |
AGA
|
Health Risk |
Pathogenic |
Aspartylglucosaminuria, Aspartylglucosaminuria |
| RS1560952256 |
AGA
|
Health Risk |
Likely pathogenic |
Aspartylglucosaminuria, Aspartylglucosaminuria |
| RS1560962569 |
GLRB
|
Health Risk |
Pathogenic |
Hyperekplexia 2, Hyperekplexia 2 |
| RS1560962636 |
GLRB
|
Health Risk |
Pathogenic |
Hyperekplexia 2, Hyperekplexia 2 |
| RS1560965164 |
NAA15
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 50 |
| RS1560966086 |
NAA15
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 50 |
| RS1560973467 |
SLC10A7
|
Health Risk |
Pathogenic |
Short stature, amelogenesis imperfecta |
| RS1560973571 |
SLC10A7
|
Health Risk |
Pathogenic |
Short stature, amelogenesis imperfecta |
| RS1560973974 |
NAA15
|
Health Risk |
Pathogenic |
NAA15-related syndrome, NAA15-related syndrome |
| RS1560977811 |
NAA15
|
Health Risk |
Likely pathogenic |
— |
| RS1560980659 |
SLC10A7
|
Health Risk |
Pathogenic |
Short stature, amelogenesis imperfecta |
| RS1560980728 |
SLC10A7
|
Health Risk |
Pathogenic |
— |
| RS1560980939 |
SDHA
|
Health Risk |
Pathogenic/Likely pathogenic |
Pheochromocytoma/paraganglioma syndrome 5, Mitochondrial complex II deficiency |
| RS1560980986 |
SDHA
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial complex II deficiency, nuclear type 1 |
| RS1560982564 |
NSUN2
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal recessive 5 |
| RS1560984816 |
DNAH5
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1560985310 |
SDHA
|
Health Risk |
Conflicting classifications of pathogenicity |
Pheochromocytoma/paraganglioma syndrome 5, Mitochondrial complex II deficiency |
| RS1560985916 |
SDHA
|
Health Risk |
Pathogenic |
Pheochromocytoma/paraganglioma syndrome 5, Mitochondrial complex II deficiency |
| RS1560986132 |
SDHA
|
Health Risk |
Pathogenic |
Mitochondrial complex II deficiency, nuclear type 1 |
| RS1560989804 |
SDHA
|
Health Risk |
Pathogenic |
Mitochondrial complex II deficiency, nuclear type 1 |
| RS1560992565 |
SDHA
|
Health Risk |
Pathogenic |
Pheochromocytoma/paraganglioma syndrome 5, Mitochondrial complex II deficiency |
| RS1560994766 |
SDHA
|
Health Risk |
Pathogenic |
Pheochromocytoma/paraganglioma syndrome 5, Mitochondrial complex II deficiency |
| RS1560998734 |
ANTXR2
|
Health Risk |
Likely pathogenic |
Hyaline fibromatosis syndrome, Hyaline fibromatosis syndrome |
| RS1561001683 |
SDHA
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial complex II deficiency, nuclear type 1 |
| RS1561002040 |
RAB33B
|
Health Risk |
Pathogenic/Likely pathogenic |
Smith-McCort dysplasia 2, Smith-McCort dysplasia 2 |
| RS1561010916 |
SDHA
|
Health Risk |
Pathogenic |
Mitochondrial complex II deficiency, nuclear type 1 |
| RS1561010948 |
SDHA
|
Health Risk |
Likely pathogenic |
Mitochondrial complex II deficiency, nuclear type 1 |
| RS1561063218 |
TRAPPC11
|
Health Risk |
Likely pathogenic |
TRAPPC11-related disorder, TRAPPC11-related disorder |
| RS1561073938 |
DNAH5
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1561081319 |
HCN1
|
Health Risk |
Pathogenic |
Generalized epilepsy with febrile seizures plus, type 10 |
| RS1561081472 |
OXCT1
|
Health Risk |
Likely pathogenic |
Succinyl-CoA acetoacetate transferase deficiency, Succinyl-CoA acetoacetate transferase deficiency |
| RS1561083229 |
NIPBL
|
Health Risk |
Pathogenic |
Cornelia de Lange syndrome 1, Cornelia de Lange syndrome 1 |
| RS1561097225 |
DNAH5
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia 3 |
| RS1561101302 |
NIPBL
|
Health Risk |
Pathogenic |
— |
| RS1561101881 |
NDUFS6
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1561102612 |
NDUFS6
|
Health Risk |
Likely pathogenic |
Mitochondrial complex I deficiency, nuclear type 9 |
| RS1561102614 |
NDUFS6
|
Health Risk |
Pathogenic |
Mitochondrial complex I deficiency, nuclear type 9 |
| RS1561102868 |
NIPBL
|
Health Risk |
Pathogenic |
Cornelia de Lange syndrome 1, Cornelia de Lange syndrome 1 |
| RS1561117442 |
MCIDAS
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1561119439 |
NIPBL
|
Health Risk |
Pathogenic |
— |
| RS1561120793 |
HCN1
|
Health Risk |
Pathogenic |
Generalized epilepsy with febrile seizures plus, type 10 |
| RS1561121987 |
CCNO
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1561122898 |
DNAH5
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1561123748 |
IL31RA
|
Health Risk |
Pathogenic |
Amyloidosis, primary localized cutaneous |
| RS1561128268 |
OXCT1
|
Health Risk |
Likely pathogenic |
Succinyl-CoA acetoacetate transferase deficiency, Succinyl-CoA acetoacetate transferase deficiency |
| RS1561136548 |
CTNND2
|
Health Risk |
Likely pathogenic |
— |
| RS1561139569 |
HCN1
|
Health Risk |
Pathogenic |
Generalized epilepsy with febrile seizures plus, type 10 |
| RS1561145912 |
NIPBL
|
Health Risk |
Pathogenic |
Cornelia de Lange syndrome 1, Cornelia de Lange syndrome 1 |
| RS1561159768 |
LIFR
|
Health Risk |
Pathogenic/Likely pathogenic |
Stuve-Wiedemann syndrome, Stuve-Wiedemann syndrome |
| RS1561164598 |
NIPBL
|
Health Risk |
Likely pathogenic |
Cornelia de Lange syndrome 1, Cornelia de Lange syndrome 1 |
| RS1561165786 |
SLC6A19
|
Health Risk |
Pathogenic |
— |
| RS1561169166 |
NIPBL
|
Health Risk |
Likely pathogenic |
Cornelia de Lange syndrome 1, Cornelia de Lange syndrome 1 |
| RS1561179103 |
MOCS2
|
Health Risk |
Pathogenic |
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B, Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B |
| RS1561179800 |
LIFR
|
Health Risk |
Conflicting classifications of pathogenicity |
Stüve-Wiedemann syndrome 1, Stüve-Wiedemann syndrome 1 |
| RS1561179853 |
LIFR
|
Health Risk |
Pathogenic |
Stuve-Wiedemann syndrome, Stuve-Wiedemann syndrome |
| RS1561180439 |
DNAJC21
|
Health Risk |
Pathogenic |
Bone marrow failure syndrome 3, Inborn genetic diseases |
| RS1561183139 |
DNAJC21
|
Health Risk |
Pathogenic |
Bone marrow failure syndrome 3, Bone marrow failure syndrome 3 |
| RS1561184482 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1561193071 |
MAP3K1
|
Health Risk |
Pathogenic |
Ovarian neoplasm, Ovarian neoplasm |
| RS1561194110 |
TERT
|
Health Risk |
Conflicting classifications of pathogenicity |
Idiopathic Pulmonary Fibrosis, Dyskeratosis congenita |
| RS1561197425 |
ARSB
|
Health Risk |
Likely pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS1561197865 |
ARSB
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis type 6, ARSB-related disorder |
| RS1561198459 |
MAP3K1
|
Health Risk |
Pathogenic |
Ovarian neoplasm, Ovarian neoplasm |
| RS1561199329 |
MAP3K1
|
Health Risk |
Likely pathogenic |
Ovarian neoplasm, Ovarian neoplasm |
| RS1561199493 |
MAP3K1
|
Health Risk |
Pathogenic |
Ovarian neoplasm, Ovarian neoplasm |
| RS1561204571 |
MAP3K1
|
Health Risk |
Pathogenic |
Ovarian neoplasm, Ovarian neoplasm |
| RS1561207924 |
NIPBL
|
Health Risk |
Likely pathogenic |
Cornelia de Lange syndrome 1, Cornelia de Lange syndrome 1 |
| RS1561213308 |
TERT
|
Health Risk |
Conflicting classifications of pathogenicity |
Idiopathic Pulmonary Fibrosis, Dyskeratosis congenita |
| RS1561213355 |
TERT
|
Health Risk |
Conflicting classifications of pathogenicity |
Dyskeratosis congenita, autosomal dominant 2 |
| RS1561213553 |
TERT
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, autosomal dominant 2 |
| RS1561213572 |
TERT
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, Dyskeratosis congenita |
| RS1561214997 |
NIPBL
|
Health Risk |
Pathogenic |
Cornelia de Lange syndrome 1, Cornelia de Lange syndrome 1 |
| RS1561215326 |
DNAH5
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia 3 |
| RS1561215364 |
TERT
|
Health Risk |
Pathogenic |
Lung sarcomatoid carcinoma, Neoplasm |
| RS1561215953 |
DNAH5
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1561222491 |
NIPBL
|
Health Risk |
Pathogenic |
Cornelia de Lange syndrome 1, Cornelia de Lange syndrome 1 |
| RS1561222655 |
NIPBL
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Cornelia de Lange syndrome 1 |
| RS1561222738 |
NIPBL
|
Health Risk |
Pathogenic/Likely pathogenic |
Cornelia de Lange syndrome 1, Cornelia de Lange syndrome 1 |
| RS1561223826 |
FGF10
|
Health Risk |
Pathogenic |
— |
| RS1561230486 |
HCN1
|
Health Risk |
Pathogenic |
Generalized epilepsy with febrile seizures plus, type 10 |
| RS1561230533 |
HCN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS1561230606 |
HCN1
|
Health Risk |
Pathogenic |
Generalized epilepsy with febrile seizures plus, type 10 |
| RS1561231553 |
NIPBL
|
Health Risk |
Likely pathogenic |
Cornelia de Lange syndrome 1, Inborn genetic diseases |
| RS1561241156 |
DNAH5
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1561243383 |
C7
|
Health Risk |
Likely pathogenic |
— |
| RS1561245416 |
MTRR
|
Health Risk |
Pathogenic |
Methylcobalamin deficiency type cblE, Methylcobalamin deficiency type cblE |
| RS1561246744 |
ETFDH
|
Health Risk |
Pathogenic |
Multiple acyl-CoA dehydrogenase deficiency, Multiple acyl-CoA dehydrogenase deficiency |
| RS1561247874 |
ETFDH
|
Health Risk |
Likely pathogenic |
Multiple acyl-CoA dehydrogenase deficiency, Multiple acyl-CoA dehydrogenase deficiency |
| RS1561251388 |
ETFDH
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple acyl-CoA dehydrogenase deficiency, Multiple acyl-CoA dehydrogenase deficiency |
| RS1561251640 |
ETFDH
|
Health Risk |
Likely pathogenic |
Multiple acyl-CoA dehydrogenase deficiency, Multiple acyl-CoA dehydrogenase deficiency |
| RS1561253718 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1561254290 |
LRBA
|
Health Risk |
Likely pathogenic |
Combined immunodeficiency due to LRBA deficiency, Combined immunodeficiency due to LRBA deficiency |
| RS1561273261 |
KIF2A
|
Health Risk |
Likely pathogenic |
Complex cortical dysplasia with other brain malformations 3, Complex cortical dysplasia with other brain malformations 3 |
| RS1561279060 |
USP53
|
Health Risk |
Pathogenic |
Cholestasis, progressive familial intrahepatic |
| RS1561291313 |
MARVELD2
|
Health Risk |
Pathogenic |
— |